SCHEMBL2462915

SCHEMBL2462915

C(=C/c1ccco1)\c1ncc[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.53
MEN1 O00255 6/20 0.53
ALDH1A1 P00352 6/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
GRM4 Q14833 1/20 0.47
KDM4E B2RXH2 4/20 0.44
MAPT P10636 4/20 0.44
TDP1 Q9NUW8 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
POLB P06746 3/20 0.44
RECQL P46063 2/20 0.44
BLM P54132 2/20 0.44
MCL1 Q07820 2/20 0.44
HCAR2 Q8TDS4 1/20 0.40
NPSR1 Q6W5P4 2/20 0.38
HTT P42858 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2462916 1.00 KMT2A (0.53) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL2789580 0.74 ALDH1A1 (0.62) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL641747 0.74 ALDH1A1 (0.62) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL2465535 0.74 NPC1 (0.44) NPC1RAB9ATLK2
SCHEMBL2465536 0.74 NPC1 (0.44) NPC1RAB9ATLK2
SCHEMBL2459141 0.72 MEN1 (0.49) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL2459140 0.72 MEN1 (0.49) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL15870919 0.72 GRM4 (0.54) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL83476 0.71 KMT2A (0.49) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL83475 0.71 KMT2A (0.49) KMT2AMEN1ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET KMT2A 4354/4885MEN1 2613/4885ALDH1A1 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.